Literature DB >> 8363220

Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.

H U Schorlemmer1, G Dickneite.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363220     DOI: 10.1111/j.1749-6632.1993.tb35862.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  1 in total

1.  Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.

Authors:  K Morikawa; K Nemoto; T Miyawaki; S Morikawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.